Towards Healthcare
Multiplex Detection Immunoassays Market Surges 9.75% CAGR by 2034

Multiplex Detection Immunoassays Market Dynamics and Strategic Insights

According to market projections, the global multiplex detection immunoassay market, valued at USD 2.82 billion in 2024, is anticipated to reach USD 7.81 billion by 2034, growing at a CAGR of 9.75% over the next decade. The increasing research in genomics, proteomics, biopharmaceuticals, and clinical diagnostics drives the market.

Content

  • Insight Code: 5217
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

Multiplex immunoassay is a technique in which several analytes can be detected and measured from the same sample fluid in a single experiment.

Multiplex immunoassay offers several advantages over conventional immunoassay. It facilitates detecting and quantifying more than analyte from a sample solution simultaneously. It requires very less amount of sample. The monitoring of numerous analytes saves time of individual analysis and improves workflows.

Multiplex immunoassays are widely used in biomarker research, new drug development, identification of protein target in a disease, clinical diagnostics, precision medicine, etc.

World Health Organization, Centers for Disease Control and Prevention, USFDA, World Stroke Organization, National Institute of Health
Any Questions